Thioproperazine ("Majeptil"), therapeutic results and complications in 63 patients with functional psychoses.
D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000139:chemically induced; D003863:Depression / Q000139:chemically induced; D005116:Extrapyramidal Tracts / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D010640:Phenothiazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011602:Psychophysiologic Disorders / Q000139:chemically induced; D011618:Psychotic Disorders / Q000188:drug therapy*; D012140:Respiratory Tract Diseases / Q000139:chemically induced; D012559:Schizophrenia / Q000188:drug therapy*; D012871:Skin Diseases / Q000139:chemically induced
D010640:Phenothiazines